Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, is proud to announce that its XERF™ system, an innovative radiofrequency (RF) technology for skin tightening, has received clearance from the U.S. Food and Drug Administration.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250818405332/en/
Cynosure Lutronic XERF™ Device
The XERF system is a groundbreaking, non-invasive solution for skin revitalization that tightens skin without the need for numbing, needles, or downtime, and is safe for all skin types.
Key Features:
- World's First Single Shot, Multifrequency Monopolar RF Technology: This innovation combines 6.78 MHz and 2 MHz frequencies, enabling providers to precisely deliver energy at multiple tissue depths, effectively heating the fibrous septa to generate both immediate and lasting skin tightening results.
- Wave Fit™ Pulse and Advanced Integrated Cryogen Delivery (ICD) Cooling Technology: These advanced technologies work in tandem to regulate energy delivery and maintain optimal surface temperature, ensuring a comfortable treatment without the need for numbing.
- Innovative Spider Pattern Tip: Designed to reduce skin edge effects, this unique tip ensures a controlled treatment environment, increasing treatment efficacy and patient safety.
“Securing clearance for the XERF device in the U.S. marks a major milestone for Cynosure Lutronic as we accelerate our growth across North America,” said Lowinn Kibbey, President, North America at Cynosure Lutronic. “The U.S. market represents one of the largest and most dynamic aesthetics markets in the world, and we’re proud to now offer patients and providers access to a breakthrough skin-tightening solution that delivers powerful results with a more comfortable, non-invasive experience.”
“As a fellowship-trained cosmetic dermatologist, we prioritize treatments in our clinic that can consistently deliver results with minimal risk and downtime. The XERF system incorporates the newest technology to safely deliver energy deeper down in the skin, while offering intelligent cooling for superior protection and patient comfort,” said Jordan V. Wang, MD, MBE, MBA, who is the Medical Director of Laser & Skin Surgery Center of Pennsylvania.
Industry Milestone and Impact
The XERF device launched in 2024 and is currently sold in Korea, Japan, Hong Kong and Canada.
For more information, please visit www.cynosurelutronic.com/xerf.
About Cynosure Lutronic, Inc
With over 30 years of combined innovation and action as the global leader in energy-based devices and superior medical aesthetic treatments, Cynosure Lutronic enables dermatologists, plastic surgeons, medical spas, and other healthcare practitioners to deliver non-invasive and minimally invasive procedures to their patients. Committed to research and development at the forefront of aesthetic technology, Cynosure Lutronic now proudly offers the most extensive portfolio of aesthetic devices in the industry, providing its customers with a more comprehensive range of solutions for skin resurfacing and revitalization, hair removal, vascular lesion treatment, skin toning, and body contouring. Cynosure Lutronic sells its products globally through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, and through international distributors in approximately 130 other countries. For more information, please visit www.CynosureLutronic.com.
CynosureLutronic.com
- The XERF™ device is indicated for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. All instances of the term “skin tightening” are used to describe tightening effects that occur via soft tissue coagulation.
- Dr. Jordan Wang is a paid consultant of Cynosure Lutronic.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250818405332/en/
Contacts
Press Contact
Kenzie Fisher
Kenzie@gcw.agency